- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/015 - Antigènes d'Hemosporidia, p. ex. antigènes de Plasmodium
Détention brevets de la classe A61K 39/015
Brevets de cette classe: 649
Historique des publications depuis 10 ans
|
43
|
44
|
48
|
35
|
43
|
41
|
27
|
27
|
43
|
20
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1651 |
24 |
| Oxford University Innovation Limited | 1561 |
22 |
| Sanaria Inc. | 36 |
20 |
| Institut Pasteur | 787 |
18 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2886 |
18 |
| BioNTech SE | 702 |
13 |
| The United States of America as represented by the Secretary of the Navy | 2787 |
10 |
| Isis Innovation Limited | 486 |
10 |
| Leidos, Inc. | 212 |
10 |
| The Trustees of the University of Pennsylvania | 4366 |
9 |
| The United States of America as represented by the Secretary of the Army | 1221 |
8 |
| Griffith University | 156 |
8 |
| Rhode Island Hospital | 201 |
8 |
| Seattle Children's Hospital, d/b/a Seattle Children's Research Institute | 135 |
8 |
| University of Washington | 2358 |
8 |
| Artificial Cell Technologies, Inc. | 19 |
7 |
| Board of Trustees of the University of Arkansas | 823 |
7 |
| GenVec, Inc. | 56 |
7 |
| The Hospital for Sick Children | 414 |
7 |
| Modernatx, Inc. | 1293 |
7 |
| Autres propriétaires | 420 |